G1 Therapeutics, Inc. Insider Trading for September 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for September 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 129,433 | |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 67.95 | 300 | 20,385 | 9,000 | 9.3 K to 9 K (-3.23 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 66.92 | 1,865 | 124,798 | 9,300 | 11.2 K to 9.3 K (-16.70 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 65.74 | 2,835 | 186,366 | 11,165 | 14 K to 11.2 K (-20.25 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 14,000 | 9 K to 14 K (+55.56 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 3,776 | 15,746 | 76,847 | |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 67.95 | 300 | 20,385 | 8,400 | 8.7 K to 8.4 K (-3.45 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 66.77 | 484 | 32,317 | 8,700 | 9.2 K to 8.7 K (-5.27 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 65.78 | 2,992 | 196,800 | 9,184 | 12.2 K to 9.2 K (-24.57 %) |
| Sep 19 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 3,776 | 15,746 | 12,176 | 8.4 K to 12.2 K (+44.95 %) |
| Sep 13 2018 | GTHX | G1 Therapeutics, I ... | Nicholson Garry A | Director | Option Exercise | A | 65.75 | 20,000 | 1,315,000 | 20,000 | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Option Exercise | M | 0.39 | 750 | 293 | 3,916 | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Option Exercise | M | 3.72 | 2,000 | 7,440 | 12,333 | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Buy | M | 3.72 | 2,000 | 7,440 | 2,000 | 0 to 2 K |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Sell | S | 59.60 | 750 | 44,700 | 0 | 750 to 0 (-100.00 %) |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Buy | M | 0.39 | 750 | 293 | 750 | 0 to 750 |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 20,607 | ||
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 60.31 | 500 | 30,155 | 0 | 500 to 0 (-100.00 %) | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 59.93 | 9,500 | 569,328 | 500 | 10 K to 500 (-95.00 %) | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Option Exercise | M | 13.51 | 3,519 | 47,542 | 92,962 | |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Sell | S | 59.98 | 3,519 | 211,065 | 0 | 3.5 K to 0 (-100.00 %) |
| Sep 06 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Buy | M | 13.51 | 3,519 | 47,542 | 3,519 | 0 to 3.5 K |